Paper32130706
The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response.
Hipólito A and 2 others. Adv Exp Med Biol, 2020. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response. Papers, record 32130706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32130706
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Humans | |
| Immunotherapy | |
| Molecular Targeted Therapy | |
| Tumor Microenvironment |
Source PubMed
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28254693 | TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation. | Biomaterials | 2017 | https://conductscience.org/library/papers/28254693 | PubMed |
| 2 | 22913968 | Glucose transporters in cancer metabolism. | Curr Opin Oncol | 2012 | https://conductscience.org/library/papers/22913968 | PubMed |
| 3 | 12833461 | A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma. | Cancer | 2003 | https://conductscience.org/library/papers/12833461 | PubMed |
| 4 | 30532012 | The lung microenvironment: an important regulator of tumour growth and metastasis. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30532012 | PubMed |
| 5 | 25512109 | Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25512109 | PubMed |
| 6 | 18824264 | Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. | Mol Immunol | 2008 | https://conductscience.org/library/papers/18824264 | PubMed |
| 7 | 26413839 | Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma. | PLoS One | 2015 | https://conductscience.org/library/papers/26413839 | PubMed |
| 8 | 26750865 | The Warburg effect and drug resistance. | Br J Pharmacol | 2016 | https://conductscience.org/library/papers/26750865 | PubMed |
| 9 | 24138885 | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Immunity | 2013 | https://conductscience.org/library/papers/24138885 | PubMed |
| 10 | 26377897 | Metabolic Reprogramming of Immune Cells in Cancer Progression. | Immunity | 2015 | https://conductscience.org/library/papers/26377897 | PubMed |
| 11 | 21107292 | The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. | J Thorac Oncol | 2011 | https://conductscience.org/library/papers/21107292 | PubMed |
| 12 | 24952473 | Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells. | Oncotarget | 2014 | https://conductscience.org/library/papers/24952473 | PubMed |
| 13 | 27387758 | Early changes in the metabolic profile of activated CD8(+) T cells. | BMC Cell Biol | 2016 | https://conductscience.org/library/papers/27387758 | PubMed |
| 14 | 26321679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 15 | 28875486 | Metabolism in Immune Cell Differentiation and Function. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/28875486 | PubMed |
| 16 | 23475953 | Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/23475953 | PubMed |
| 17 | 25056707 | Non-small-cell lung cancers: a heterogeneous set of diseases. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25056707 | PubMed |
| 18 | 25857315 | New horizons in tumor microenvironment biology: challenges and opportunities. | BMC Med | 2015 | https://conductscience.org/library/papers/25857315 | PubMed |
| 19 | 23261227 | Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. | Lung Cancer | 2013 | https://conductscience.org/library/papers/23261227 | PubMed |
| 20 | 29248722 | Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer. | Free Radic Biol Med | 2018 | https://conductscience.org/library/papers/29248722 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42435178 | Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435178 | PubMed |
| 42435166 | Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435166 | PubMed |
| 38990147 | Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells. | Biosci Rep | 2024 | https://conductscience.org/library/papers/38990147 | PubMed |
| 38628288 | A metabolomics study on carcinogenesis of ground-glass nodules. | Cytojournal | 2024 | https://conductscience.org/library/papers/38628288 | PubMed |
| 38247476 | H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38247476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32130706
GET https://conductscience.org/api/papers/v1/32130706/references?page=2